Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Official URL: https://nshr-uat.sha.go.ke/fhir/ValueSet/nccp-med-admin-route-vs | Version: 0.1.0 | ||||
| Active as of 2026-06-04 | Computable Name: MedAdminRouteVS | ||||
Routes by which oncology medications are administered.
References
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs version 📦0.1.0
Expansion performed internally based on codesystem Kenya Medication Administration Route Code System v0.1.0 (CodeSystem)
This value set contains 16 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | IV-BOLUS | Intravenous Bolus | Direct IV injection over <5 minutes. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | IV-PUSH | Intravenous Push | IV injection over 5–15 minutes. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | IV-INFUSION-SHORT | IV Short Infusion | IV infusion over 15 minutes to 3 hours. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | IV-INFUSION-LONG | IV Long Infusion | IV infusion over >3 hours or continuous infusion. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | ORAL | Oral | By mouth (tablets, capsules, solution). | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | SUBCUTANEOUS | Subcutaneous | Injection into subcutaneous tissue. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRAMUSCULAR | Intramuscular | Injection into muscle. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRATHECAL | Intrathecal | Into the cerebrospinal fluid (spinal canal). | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRAVESICAL | Intravesical | Into the bladder lumen. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRAPERITONEAL | Intraperitoneal | Into the peritoneal cavity. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRAPLEURAL | Intrapleural | Into the pleural cavity. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | TOPICAL | Topical | Applied to skin surface. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | TRANSDERMAL | Transdermal | Through intact skin via patch. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INHALED | Inhaled | Via inhalation. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRALESIONAL | Intralesional | Injected directly into the lesion. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs | INTRA-ARTERIAL | Intra-arterial | Into a feeding artery (e.g., hepatic artery infusion). |